In US, GLP-1s cost hundreds more than similar nations

Glucagon-like peptide-1 receptor agonists, which include Ozempic and Mounjaro, cost between five to 10 times more in the U.S. than other wealthy nations, according to research KFF published Aug. 17.

Advertisement

In the U.S., Type 2 diabetes drugs Ozempic, Rybelsus and Mounjaro, and the weight loss medication Wegovy, cost between $936 and $1,349 for a month’s supply. 

Japan, the country with the second-highest average cost for this popular class of medications, is five times less. There, Ozempic costs about $170, Rybelsus is $69 and Mounjaro is about $320. 

List prices in other nations are significantly 10 times less: In France, Australia, the U.K., Sweden the Netherlands and Germany, Ozempic is between $80 and $100, according to the analysis. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.